Targeting of drugs and strategies for stealth therapeutic systems, 1998
Strategies for Stealth Therapeutic Systems

Nato Science Series A: Series, Vol. 300

Coordinators: Gregoriadis Gregory, McCormack Brenda

Language: Anglais
Cover of the book Targeting of drugs and strategies for stealth therapeutic systems

Subject for Targeting of drugs and strategies for stealth...

137.14 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Targeting of Drugs 6
Publication date:
302 p. · 17.8x25.4 cm · Paperback

Approximative price 289.00 €

Subject to availability at the publisher.

Add to cartAdd to cart
Targeting of drugs and strategies for stealth therapeutic systems
Publication date:
286 p. · Hardback
Interactions between Blood Components and Artificial Surfaces, K.D. Caldwell. The Mononuclear Phagocyte System: Features Relevant to Interactions with Liposomes, S. Gordon. StealthTM Therapeutic Systems: Rationale and Strategies, D.J.A. Crommelin, G. Storm. Long Circulating Liposomes: Evolution of the Concept, G. Gregoriadis. Sterically Stabilized Immunoliposomes: Formulations for Delivery of Drugs and Genes to Tumor Cells in Vivo, J.W. Park, et al. Pegylation of Liposomes in Cell-Specific Targeting: It Does Not Always Make Sense, G.L. Scherphof, et al.. StealthTM Liposomes for the Targeting of Drugs in Cancer Therapy, T.M. Allen, et al. StealthTM Liposomes as Carriers of Doxorubicin, D. Goren, et al. Liposome-Mediated Delivery of Retinoids, K. Mehta, et al. Applications of Liposome Technology to Overcome Multidrug Resistance in Solid Tumors, R. Krishna, L.D. Mayer. Use of Radiolabeled Liposomes for PEG-Liposome-Based Drug Targeting and Diagnostic Imaging Applications, W.T. Phillips. Diagnostic and Therapeutic Targeting of Infectious and Inflammatory Diseases Using Sterically Stabilized Liposomes, G. Storm, et al. Biologically Active Ligand-Bearing Polymer-Grafted Liposomes, S. Zalipsky, et al. 11 Additional Articles. Index.
Interactions between Blood Components and Artificial Surfaces, K.D. Caldwell. The Mononuclear Phagocyte System: Features Relevant to Interactions with Liposomes, S. Gordon. StealthTM Therapeutic Systems: Rationale and Strategies, D.J.A. Crommelin, G. Storm. Long Circulating Liposomes: Evolution of the Concept, G. Gregoriadis. Sterically Stabilized Immunoliposomes: Formulations for Delivery of Drugs and Genes to Tumor Cells in Vivo, J.W. Park, et al. Pegylation of Liposomes in Cell-Specific Targeting: It Does Not Always Make Sense, G.L. Scherphof, et al.. StealthTM Liposomes for the Targeting of Drugs in Cancer Therapy, T.M. Allen, et al. StealthTM Liposomes as Carriers of Doxorubicin, D. Goren, et al. Liposome-Mediated Delivery of Retinoids, K. Mehta, et al. Applications of Liposome Technology to Overcome Multidrug Resistance in Solid Tumors, R. Krishna, L.D. Mayer. Use of Radiolabeled Liposomes for PEG-Liposome-Based Drug Targeting and Diagnostic Imaging Applications, W.T. Phillips. Diagnostic and Therapeutic Targeting of Infectious and Inflammatory Diseases Using Sterically Stabilized Liposomes, G. Storm, et al. Biologically Active Ligand-Bearing Polymer-Grafted Liposomes, S. Zalipsky, et al. 11 Additional Articles. Index.